William Lavery is a partner in the Antitrust and Competition Practice of Baker Botts’ Washington, D.C. office. Some of the world’s largest companies rely on Mr. Lavery’s more than a decade of experience for major “bet the company” antitrust litigations, criminal and civil antitrust investigations, and mergers. Clients in industries including technology, foundry, pharmaceutical, chemical, energy, transportation and agriculture seek Mr. Lavery’s representation in cases alleging a broad range of antitrust violations, including price-fixing, monopolization, Robinson-Patman violations, and sham litigation. Mr. Lavery also represents numerous companies in internal investigations and in implementing antitrust compliance programs.
819
On April 13, 2021, the U.S. Court of Appeals for the Fifth Circuit upheld the Federal Trade Commission’s (“FTC” or “Commission”) ruling that the “reverse-payment” settlement agreement between Endo Pharmaceuticals Inc. (“Endo”) and Impax Laboratories LLC (“Impax”) violated federal antitrust laws. The (...)
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 149
New York, NY, 10001, USA
563 Chiswick High Road
W4 3AY London, UK
